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ABSTRACT

EXPRESSION OF ALPHA3 BETA2 NEURONAL NICOTINIC
ACETYLCHOLINE RECEPTOR SUBUNITS IN HEK-293 CELLS

Nathan W. Steinhafel
Department of Physiology and Developmental Biology
Master of Science

Single-cell real-time quantitative RT-PCR was used to characterize the
mRNA expression of rat neuronal nicotinic acetylcholine receptor (nAChR)
subunits α3 and β2 in CA1 hippocampus stratum radiatum and stratum oriens
interneurons. α3β2 co-expression was detected in 43% of interneurons analyzed.
The nAChR subtype α3β2 was transiently expressed in cells derived from the
human embryonic kidney cell line 293 at mRNA levels found in the CA1. The
functional properties of α3β2 in HEK-293 cells were characterized by whole-cell
patch clamping using acetylcholine (ACh) as an agonist. The kinetics of α3β2
channels were further analyzed by altering the level of α3 DNA transfected into
HEK-293 cells. Varying the α3 concentration by more than 100,000 fold did not

significantly alter the majority of the kinetics; the 10%-90% rise-time was the
main characteristic found to be significantly different. A decrease in α3
concentration illustrated a significant increase in rise time.

This and future

studies will further our understanding of the extensive role neuronal nAChRs play
in modulating hippocampal activity and consequently influencing cognition and
memory.
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INTRODUCTION
Ionotropic

neuronal

nicotinic

acetylcholine

receptors

(nAChRs)

are

heterogeneous cationic channels that are widely expressed in the central and peripheral
nervous system (CNS, PNS), where their opening is controlled by endogenous
acetycholine (ACh) or exogenous agonists such as nicotine.

They consist of

homopentameric or heteropentameric subtypes that are involved in a variety of
physiological processes including neuronal development, learning and memory
formation, and reward (Jones and Yakel 1999; Gotti, Zoli et al. 2006).

More

importantly, nAChR dysfunction throughout the CNS has been shown to be key in the
cognitive impairments of neurodegenerative diseases including Alzheimer’s (Nordberg,
Alafuzoff et al. 1986; Perry 1995; Dani 2001), schizophrenia (Freedman, Coon et al.
1997; Breese, Lee et al. 2000), and even aging (Jones and Yakel 1999). However,
many of the cellular and molecular mechanisms of these diverse conditions and their
involvement with nAChRs are currently unknown.

Different types of cognitive

pathologies seem to involve dysfunction of specific combinations of α and β nicotinic
receptor subtypes (Martin-Ruiz, Court et al. 1999; Durany, Zochling et al. 2000;
Leonard, Breese et al. 2000).

Accordingly, drugs could be designed to interact

selectively at a nAChR subtype and therefore provide different therapeutic opportunities
for treating cognitive related diseases.

Better understanding of the role nicotinic

receptor subtypes play in the CNS and PNS may provide development of safe and
effective therapeutic agonists for treating a variety of cognitive dysfunctions.
Therefore, to enhance our understanding of the pharmacological and physiological
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properties of neuronal nAChRs, we must investigate how their subunits assemble to
form functional channels.
Neuronal nAChRs are members of a large, structurally related ligand-gated ion
channel superfamily, together with GABAA, glutamate, glycine, and 5-HT3 receptors
(Ortels et al, 1995). Neuronal nAChRs are located in a variety of CNS locations (i.e.
basal ganglia, thalamus, cerebellum, striatum, and hippocampus) (Bourin, Ripoll et al.
2003; Gotti, Zoli et al. 2006), and can be found in both pre-synaptic and post-synaptic
locations.

ACh-mediated innervation acting through nAChRs regulates crucial

processes such as transmitter release, cell excitability, and neuronal integration (Gotti,
Fornasari et al. 1997; Newhouse, Potter et al. 1997; Wonnacott 1997; Jones and Yakel
1999). Like every member of the ligand-gated ion channel family, the nAChR is a
transmembrane receptor protein complex consisting of five polypeptide subunits
arranged around a central pore that is permeable to cations (Bourin, Ripoll et al. 2003)
(Figure 1). Thus far separate genes for α2-10 and β2-4 nAChR subunits have been
identified. These receptors are known to be expressed in a variety of two- and threeway subunit combinations (Dani 2001; Gotti, Zoli et al. 2006) (Figure 2). Although
many subunit combinations have been identified in the CNS, the most commonly
discovered mammalian neuronal nAChRs with a high affinity for agonists contain α7 or
α4/β2 subunits which form homomeric or heteromeric complexes, respectively
(Changeux, Bertrand et al. 1998). In addition, α3/β4, a highly expressed nAChR in the
autonomic nervous system, has also been found to be a combination involved in
cognitive
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Figure 1. Pentameric assembly of a nACHR. Shown: a dimer nAChR
subtype, α4β2 (Illustration by: Georgi 2004).
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Figure 2. Regional distribution and subunit organization of the main nicotinic
acetylcholine receptor subtypes in the rodent CNS. The subtypes present in the
cortex, cerebellum, hippocampus, interpeduncular nucleus, medial habenula and
pineal gland have been identified by binding, immunoprecipitation and/or
immunopurification assays in tissue from rat and/or wild-type and/or receptor
subunit knockout mice. The subtypes present in the amygdala, hypothalamus,
locus coeruleus, olfactory bulb, raphe nuclei, spinal cord, substantia nigra–ventral
tegmental area and thalamus have been deduced from in situ hybridization, singlecell PCR and binding studies of tissues obtained from rat and/or wild-type and/or
knockout mice [Illustration and reviewed by: (Gotti, Zoli et al. 2006)].
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function (Alkondon, Rocha et al. 1996; Albuquerque, Alkondon et al. 1997; Gotti, Zoli
et al. 2006). The CNS location as well as the pentameric co-assembly of different
neuronal nAChR subunits largely determines the physiological action and biophysical
and pharmacological properties of neuronal nAChRs (Wada, Wada et al. 1989;
Alkondon, Rocha et al. 1996; Changeux, Bessis et al. 1996; Gotti, Fornasari et al.
1997).
The hippocampus is highly heterogeneous in neuronal nAChR expression
(Albuquerque, Pereira et al. 1997; Frazier, Rollins et al. 1998; McQuiston and Madison
1999; Sudweeks and Yakel 2000; Gotti, Zoli et al. 2006). The hippocampus has direct
connections to the entorhinal cortex (via the subiculum) and the amygdala. Outputs
from these structures can then have an effect on many other areas of the central nervous
system. For instance the entorhinal cortex projects to the cingulate cortex, which has a
connection to the temporal lobe cortex, orbital cortex, and olfactory bulb. Thus, all of
these areas can be influenced by hippocampal output, primarily from the output of the
CA1 region. Nicotinic acetylcholine receptors within hippocampal interneurons are
involved in fast synaptic transmission in the hippocampal CA1 stratum oriens and
stratum radiatum subfields. There is cholinergic innervation to the hippocampus from
the medial-septum diagonal band complex from the basal forebrain (Frotscher and
Leranth 1985) and there are cholinergic synapses between normal hippocampal
interneurons (Matthews, Salvaterra et al. 1987). Also, previous research has shown that
hippocampal interneurons contain GABAergic projections onto the more frequent CA1
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pyramidal neurons, regulating the excitability of the pyramidal cells (Jones and Yakel
1999).
Furthermore, it has previously been demonstrated that rat hippocampal
interneurons express neuronal nAChRs in a manner homologous to humans (Jones and
Yakel 1997). Of the 11 different nAChR subunits known; eight of these (α2-α5, α7, and
β2-β4) are expressed in the rat hippocampus (Sudweeks and Yakel 2000). The nAChRs
in hippocampal interneurons are in a key location to be involved in modulating
cognitive functions because interneurons play a major role in coordinating hippocampal
activity (Freund and Buzsaki 1996; Jones and Yakel 1999). Altered synaptic plasticity
has been shown to change the dynamic interactions among hippocampal networks
causing age-related cognitive impairments (NIA/NIH 1999; Pauly 1999; Bourin, Ripoll
et al. 2003; Grassi, Palma et al. 2003; Lamb, Melton et al. 2005). Consequently,
nAChRs are assumed to be involved in cognitive diseases including Alzheimer’s
disease (AD). For example, revealed by behavioral and electrophysiological studies,
evidence implicates the α7 nAChR subtype as being linked to AD (Gotti, Fornasari et
al. 1997). AD is characterized by accumulation of senile plaques, mainly composed of
beta-amyloid peptide (Aβ). Even though the exact causes of AD are unknown, different
pathogenesis hypotheses implicating nAChRs made up of α7 subunits have been
proposed, with the receptors exerting a direct or indirect action on the mechanism of Aβ
toxicity. The application of Aβ has recently been shown to impede nAChR function in
rat hippocampal neurons (Liu, Kawai et al. 2001; Pettit, Shao et al. 2001).
Many studies suggest that interneurons within the hippocampus express
primarily homomeric and heteromeric combinations of α7 and α4/β2, respectively.
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However, various studies involving pharmacology (Xiao and Kellar 2004),
electrophysiology (Khiroug, Harkness et al. 2002), knock-out mice and RT-PCR
(Sudweeks and Yakel 2000) have revealed a variety of other heteromeric nAChR
subunit combinations. For example, previous pharmacological studies have suggested
that α7-containing nAChRs are functionally expressed in most hippocampal
interneurons, but the incomplete block by α7-specific antagonists suggest that there is a
class of non-α7-containing receptors (Alkondon, Pereira et al. 1998; Frazier, Rollins et
al. 1998; McQuiston and Madison 1999). Furthermore, comparing the properties of
heterologously expressed channels with those of native nAChRs from hippocampal
electrophysiological recordings, it is clear that composition of the native receptors is
more complicated than just α7 and α4β2. For example in the CA1 stratum oriens the
slow nAChR-mediated response usually expected from an α4-containing nAChR
(Albuquerque, Pereira et al. 1995) was not as sensitive to the broad spectrum non-α7
nAChR antagonist, dihydro-β-erythroidine (DHβE); (McQuiston and Madison 1999),
suggesting the involvement of an alpha subunit such as α2 or α3. For instance, this
response was not blocked by α-CTX MII (which does block α3 containing receptors),
suggesting that it may be partly mediated by an α2-containing receptor (McQuiston and
Madison 1999; Khiroug, Khiroug et al. 2004). Accordingly, the α2 as well as the α3
subunit might be a key component in forming functional two-way and even three-way
nAChRs.
The relatively small number of subtype-specific pharmacological agents
available has limited progress in characterizing the roles of many subunit combinations.
In order to more accurately understand the function of nAChRs in areas with highly
7

heterogeneous expression, such as the hippocampus, we need to conduct studies with
tools other than just pharmacology. Quantitative information on the relative expression
levels of individual neuronal nAChR subunit mRNA may provide an avenue for
effectively defining and categorizing neuronal nAChR subtypes. Single-cell RT-PCR
studies along with in situ hybridization have revealed significant levels of α2-α5, α7,
and β2-β4 nAChR subunit mRNA expression in interneurons within the hippocampus
CA1 stratum oriens and stratum radiatum and other regions of the CNS (Wada, Wada
et al. 1989; Sudweeks and Yakel 2000). In addition, it has been demonstrated that
many of these subunits are significantly co-expressed together in individual neurons
(Sudweeks and Yakel 2000).
Expressing recombinant ion channels in heterologous expression systems has
been traditionally used to characterize their functional properties (e.g., kinetics,
conductance, ion selectivity, agonist activity, pharmacology, etc.).

Successful

expression of two-subunit neuronal nAChR combinations has been achieved using
human Xenopus laevis oocytes (Elliott, Ellis et al. 1996; Chavez-Noriega, Crona et al.
1997; Fenster, Rains et al. 1997; Nelson and Lindstrom 1999; Figl and Cohen 2000;
Khiroug, Harkness et al. 2002) and less commonly human embryonic kidney- (HEK-)
293 cells (Figure 3) (Wang, Nelson et al. 1998; Nelson, Wang et al. 2001; Khiroug,
Harkness et al. 2002; Xiao and Kellar 2004). To date, the characterization of the rat
neuronal α3β2 nAChR in HEK-293 cells has been rarely studied (Xiao and Kellar
2004). However more frequent studies have been done using Xenopus laevis oocytes
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Figure 3. Confocal microscopy of HEK-293 cells with α3β2 nAChRs. Green
reflects labeling of α3 subunits by Alexa 488-labeled mAb 210. Red reflects
secondary labeling by Alexa 594-labeled GART antibody against mAb 295
which bound β2 subunits. Yellow is a result of overlap in the labeling of
colocalized subunits [photo and research by: (Nelson, Wang et al. 2001)].
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(Luetje and Patrick 1991; Chavez-Noriega, Crona et al. 1997; Fenster, Rains et al. 1997;
Figl and Cohen 2000). Moreover, very few, if any, studies have yet been carried out
using three-way rat neuronal nAChR subunit combinations in HEK-293 cells. In this
study, we use single-cell real-time quantitative RT-PCR to characterize the mRNA
expression of rat neuronal nAChR α3 and β2 nAChR subunits mRNA in CA1
hippocampus stratum radiatum and stratum oriens interneurons. This provides insight
into how often these subunits are expressed together, and what the actual mRNA ratios
are in individual interneurons when the subunits are co-expressed.
Our study constitutes one of the first studies, to date, to identify native rat
neuronal nAChR subunit mRNA co-expression ratios, reconstitute them in HEK-293 at
the same ratios to form functional channels, and analyze their functional properties in
HEK-293 cells. This and future studies will further our understanding of the substantial
role these receptors play in modulating hippocampal activity and thereby influencing
cognition and memory.
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MATERIALS AND METHODS
Slice Preparation and Cytoplasm Aspiration
All CA1 hippocampal slice and interneuron aspiration experiments were
prepared and carried out as described previously (Sudweeks and Yakel 2000). In brief,
coronal brain slices (either 300 or 350 µm thick) were made from Wistar rats (8-23 days
old) using a Vibratome 1000-Plus (Pelco, Redding, CA). Cut in ice-cold oxygenated
(95% O2, 5% CO2) artificial cerebro-spinal fluid (ACSF in mM: 124 NaCl, 2 KCl, 1
NaH2PO4, 26 NaHCO3, 11 Glucose, 2 CaCl2, 1 MgSO4), the slices were placed in
room-temperature oxygenated ACSF for at least 30 minutes prior to placing in
microscope recording chamber.
Individual hippocampal interneurons from the CA1 stratum oriens and
stratum radiatum were visually identified using an upright microscope with infrared
lighting (Figure 4) and aspirated into a standard whole-cell patch-clamp pipette (Figure
5) (Borosilicate capillaries, Harvard Apparatus, Kent, England) containing 5 µL
intracellular fluid (ICF in mM: 10 MgCl2, 0.1 CaCl2, 1 EGTA, 10 HEPES, 135 KGluconate, Na-2 ATP).
Electrophysiology in CA1 Hippocampal Interneurons
A whole-cell patch clamp of the interneuron was obtained in voltage-clamp
mode prior to cytoplasm aspiration. Interneuron membrane potentials were held at
negative 70mV.
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Stratum oriens

CA1
Stratum radiatum

CA3

Figure 4. Rat hippocampal slice indicating regions where interneurons were
aspirated. Inset shows a stratum radiatum interneuron (Photo by: Sudweeks
2002)
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Figure 5. Screenshot of a whole-cell patch-clamp pipette on an
interneuron in the CA1 stratum oriens prior to aspiration (Photo
by: Burgon 2005).
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Primers and Probes
Primers and probes were purchased from Invitrogen. The primers and probes
were designed using either Vector NTI version 7.0 (Invitrogen) or Primer Express
version 2.0 (ABI Prism) software (Burgon 2005).
RT Reaction
A cDNA library representing each CA1 hippocampal interneuron was made by
running a reverse transcription reaction using BIORAD iScript cDNA Synthesis Kit with
a final volume of 10 µl (Burgon 2005).
Multiplex Reaction and Real-time Quantitative PCR
A multiplex PCR reaction was run (15 cycles) for each aspirated interneuron
using all neuronal nAChR primers as well as primers for 18s rRNA with a final volume
of 75 µl.

The multiplex reaction was run using reagents by Invitrogen including

Platinum® Taq DNA Polymerase and PCR nucleotides (10mM). A second round of
PCR was run (60 cycles) for each specific target (18s, α2, α3, and β2) using an ABI
7000 Sequence Detection System (Applied Biosystems, Foster City, CA) utilizing
BIORAD iTaq Supermix with ROX (Invitrogen). Cycle threshold values for each target

were compared to the reference gene 18s for analysis (more in Real-Time Analysis).
Standard curves (efficiency of amplification tests) for each cDNA target were
developed by running 60-cycle real-time quantitative PCR assays on positive controls
(rat whole-brain homogenate) for six known concentrations (100, 33.3, 10, 3.33, 1,
0.333 ng cDNA/µL).

Upstream (primer +) and downstream (primer –) primer

concentrations were adjusted to optimize amplification as reported previously. The
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efficiency of the amplification reaction is calculated using the slope of the log
(concentration) vs. CT plot. The formula for PCR efficiency (Bustin 2004):

10( −1 / slope) − 1
Reaction efficiencies were run in triplicate and the amplification efficiencies were
compared using an ANOVA to determine if there were significant differences between
any of the primer/probe sets (18s, α2,α3, and β2) (Burgon 2005).
Real-Time Analysis
After running the real-time quantitative PCR on hippocampal interneurons, raw
fluorescence (Delta Rn) values across 60 cycles were curve-fit using a Boltzmann
Sigmoidal function with an output of either 2000 or 4000 data points in the new curve
using GraphPad 4.0 (Graphpad, Prism) software. The second derivative graph for the
curve-fit data was then determined, also using Graphpad. The cycle threshold (CT)
value used for quantitative analysis was determined by finding the cycle number (along
the x-axis) corresponding to the maximum Delta Rn value (along the y-axis), as
described previously (Bustin 2004).
Primer Efficiencies Analysis
Triplicate reactions of each cDNA target were averaged and a linear regression
equation was calculated (SLOPE function, Microsoft Excel) of the CT values
corresponding to the six known concentrations (100, 33.3, 10, 3.33, 1, 0.333 ng
cDNA/µL) in the standard curve primer efficiency tests. The PCR efficiency was then
determined by incorporating the slope of the linear equation using the formula described
above (see Multiplex Reaction and Real-time Quantitative PCR) (Burgon 2005).
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mRNA Expression Analysis
For comparison between cDNA targets, fold expression values from the
triplicate CT averages were calculated as reported previously, but compared to the CT
value corresponding to the lowest level of cDNA detection (Livak and Schmittgen
2001). Significance between relative levels of mRNA expression was calculated by
comparing mean fold expression values using a Mann-Whitney test (calculated using
InStat ver. 3.05, Graphpad software) (Burgon 2005).
Plasmid DNA Preparation
The rat α3 and β2 genes were put in the pcDNA 3.1 plasmid (Invitrogen) using
a digestion and ligation protocol from New England Biolabs and Bioline, respectively.
Green florescence protein plasmid was kindly provided by Dr. Michael Stark (Brigham
Young University, Provo, UT). All plasmids were grown-up using a transformation
protocol by Yeastern Biotech and carried out in accordance with its guidelines. A
plasmid isolation and purification protocol was followed by HiSpeed®, a plasmid
purification kit by QIAGEN Inc. (USA).
Tissue Culture
Human embryonic kidney (HEK) -293 cells were kindly provided by Dr. Barry
Willardson (Brigham Young University, Provo, UT). HEK-293 cells were grown and
maintained on 60 mm surface petri dishes coated with nunclon (Nunc) containing 1.6
ml of complete medium: Dulbecco’s Modified Eagle medium (DME) (Nova-Tech, Inc.
Grand Island, NE) supplemented with 10% fetal bovine serum (FBS) and 1.25%
Penicillin. HEK-293 cells were stored in an incubator humidified to 37 degrees Celsius
containing 5% CO2. HEK-293 cells were grown up three to four days until a suitable
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density of cells was achieved (75-85% confluence). This was visually approximated
using a light microscope.
Approximately 24 hours preceding transfection, 1ml of HEK-293 cells at 7585% confluence were triturated and plated onto 30 mm diameter petri dishes coated
with nunclon (Nunc) containing 1ml of warmed complete medium in order to obtain 5070% confluence the following day (Figure 6). This was followed by incubation (37
degrees Celsius, 5% CO2) overnight.
Expression in HEK-293 Cells
Transfection into HEK-293 cells was accomplished using a protocol by Mirus.
TransIT-293 Reagent (3-4 µl per 1 µg plasmid DNA) was placed directly into 200 µl of
serum-free DME and incubated at room temperature for 15-20 minutes. DNA (α2 or
β2, and GFP) (Table 1) was added to the TranIT-293 Reagent and mixed by gentle
pipetting. This reagent/DNA complex was allowed to incubate at room temperature for
15-30 minutes. The reagent/DNA complex was placed drop wise onto HEK-293 cells.
This was followed by incubation (37 degrees Celsius, 5% CO2) overnight. Two control
cells were used: Non-transfected HEK-293 cells and GFP-only transfected HEK-293
cells.
Twenty-four hours preceding electrophysiological recordings, three 10.5 mm
diameter cover slips treated with thermanox (Nunc) were positioned in a 30 mm petri
dish containing 1 ml warmed complete medium.

Subsequently, 500 µl triturated

transfected HEK-293 cells were placed drop wise overlaying the cover slips. The cells
were then returned to incubate (37 degrees Celsius, 5% CO2) for approximately 12-15
hours.
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Figure 6. Light microscopy of HEK-293 cells grown on a
30 mm petri dish treated with nunclon (Nunc) 12 hours
prior to transfection (Screen shot by: Steinhafel 2003)
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Rat neuronal nAChR
combination

[α3 in pcDNA 3.1]

[β2 in pcDNA 3.1]

[GFP-pcL
plasmid]

0 µg

0 µg

1 µg

α3β2a

1/(2^17) µg

1 µg

1 µg

α3β2b

1 µg

1 µg

1 µg

Control

Table 1. Relative nAChR subunit concentration added to transfection reagent
complex. α3β2a contains ~100,000 fold less α3 compared to α3β2b.
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Electrophysiological Recordings on HEK-293 Cells
Transfected HEK-293 Cells were visually identified using fluorescence on an
inverted microscope. Whole-cell configuration patches were formed on transfected
HEK-293 cells growing on the cover slips. Recordings were performed in an extra
cellular like solution (ECF) containing (in mM) NaCl (126), KCl (6), CaCl2·2H20 (1.2),
MgCl (2.5), HEPES (10), Glucose (11) (pH 7.4). Current responses were obtained by
voltage-clamp recording at a holding potential of -70 mV using a MultiClamp 700A and
pCLAMP 9.2 software (Axon Instruments) (Figure 7). Traces were filtered at 1 kHz
and sampled at 10 kHz. Electrodes containing an intracellular like solution [ICF in
mM: 5 NaCl, 147 KCl, 1.2 CaCl2·2H20, 20HEPES, 11 Glucose, 5 ATP (pH 7.2)] were
formed from borosilicate glass capillaries (Harvard Apparatus, Kent, England) and had
resistances of typically 3-6 MΩ when filled with ICF. ACh was freshly prepared in
ECF solution, placed into a borosilicate glass electrode, and applied using the
Picospritzer® III (Parker Hannifin Instrumentation). All compounds were obtained
from Fischer Scientific and Sigma-Aldrich.
Recording Acquisition and Analysis
Peak currents, 10-90 rise times, 90-10 decay times, curve-fitting and
desensitization were measured and using Clampfit 9.2.0.11 (Axon Instruments) and
analyzed with Microsoft Excel and GraphPad 4.0 (Graphpad, Prism). A standard twotailed T Test was used to test differences between the two α3β2 groups based on these
individual variables. A Mann-Whitney Test, a common post-hoc test, was used to verify
significant differences in comparisons not amenable to using parametric statistics. On
all tests, P values less than 0.05 were considered significant. GraphPad together with
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Microsoft Excel was used to identify descriptive statistics including means and standard
deviations.
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Figure 7. Illustration of a screen shot simulating
one-electrode voltage-clamp in whole cell mode
(Photo by: NeuroSearch, Denmark).
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RESULTS
Neuronal nAChR subunit expression from rat CA1 hippocampal interneurons
Ninety-Three

interneurons

were

aspirated

from

acutely

prepared

rat

hippocampal slices from the CA1 stratum oriens and stratum radiatum were
individually analyzed for their mRNA expression of the neuronal nAChR α2−10, and
β2-β4 subunits, along with 18s rRNA. Out of 93 hippocampal interneurons analyzed
10.8% had no detectable nAChR subunits, 45.2% had a unique combination, 25.8% had
a combination that was observed twice, 9.7% had a combination that was observed 3
times, and 8.6% had a combination that was observed 4 times (Figure 8). The most
common single cell combinations were α3α4α5α7β2 and α3α5β2β3β4, both of which
contain α3 and β2. A z-test of two proportions did not demonstrate any significant
differences between the proportion of cells expressing the α3 or β2 subunits when
comparing the stratum radiatum and the stratum oriens cells in this sample, so the data
from the two cell layers was pooled into a single set. α3β2 was detected in 43% (n=36)
of interneurons containing nicotinic receptors (n=83).
Heterologous expression of rat α3β2 nAChR channels
Various combinations of the plasmids containing the α3 and β2 neuronal
nAChR genes were successfully transfected into HEK-293 cells along with a plasmid
containing green fluorescent protein (GFP). The GFP allowed for the visual detection
of those cells which had been successfully transfected (Figure 9).

A 500 ms

application (unless stated otherwise) of ACh [10mM] was used to elicit nAChR current
responses in whole-cell voltage-clamped HEK-293 cells expressing the rat α3β2
neuronal nAChR subunit combination at a holding potential of -70 mV (Figure 10) but
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did not excite the non-transfected HEK-293 cells (n=10) or the GFP-only transfected
HEK-293 cells (n=14). The existence and function of α3β2 nAChRs after a significant
reduction in α3 transfection validates the capability of HEK-293 cells to assemble
and/or process the mature protein properly. Dissimilar characteristics of these two
receptors suggest different possible mechanisms of assembly and therefore two different
possible stoichiometries.
10%-90% Rise Times
The 10%-90% peak rise times from ACh elicited currents were measured using
Clampfit and analyzed by GraphPad (see Materials and Methods). The HEK-293 cells
transfected with α3β2 (n=9, unless stated otherwise) at a DNA ratio of approximately
1/(2^17):1 revealed a faster average rise time (10-90%) of 378.7 ms ± 188.7. Those
cells transfected with α3β2 (n=23, unless stated otherwise) at DNA ratios 1:1 were
observed having a slower average rise time of 724.3 ms ± 244.0 (Figure 11). A twotailed T Test (P value = 0.006) together with a Mann-Whitney Test (P value = 0.0022)
revealed a significant difference in rise times between these two groups of receptors
(Table 2).
90%-10% Decay Times
HEK-293 cells transfected with α3β2 1/(2^17):1 revealed channels having an
average decay time (90-10%) of 2502 ms ± 888.5. Those cells transfected with α3β2
1:1 were observed containing channels having an average decay time of 3051 ms ±
1792 (Figure 12) . A two-tailed T Test together with a revealed no significant
differences in decay times between these two groups of receptors (Table 3).
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PCR Data: # of times a unique nACHR
combination was observed
50%
40%
30%
20%
10%
0%
0

1 time

2 times

3 times

4 times

Figure 8. PCR Data on CA1 rat hippocampal interneurons. The number
of times a specific group of nAChR subunits were found in an interneuron.
n=93.
α3α4α5α7β2 and α3α5β2β3β4 were seen in 4 cells each.,
interestingly, α3 and β2 were found in both of these groups.
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Figure 9. Microscopy of transient transfected HEK-293 cells
expressing α3β2 nAChRs and green-florescent protein (GFP) when
exposed to blue UV-light. Cells which do not fluoresce were not
successfully transfected with either α3β2 or GFP (data not shown)
(Screen shot by: Steinhafel 2003).
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Figure 10. Altering the α3 concentration of α3β2 did not significantly alter the kinetics
when expressed in HEK-293 cells. The application of ACh (10mM; indicated by the
500 ms horizontal bar) on α3β2 nAChR transfected cells induced a rapid inward
current at a -70 mV holding potential that rapidly desensitized.
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Desensitization
When subjected to prolonged exposure to nicotinic agonists, nicotinic
acetylcholine receptors undergo desensitization, resulting in an inactive receptor that
does not allow for the passage of ions. Rates of recovery from desensitization are
dependent on the receptor subunit composition, length of agonist exposure, and on the
agonist used to induce desensitization. Furthermore, nicotinic receptor desensitization
may contribute to behavioral changes in humans or animals subjected to prolonged
nicotine exposure pharmacologically or through the use of tobacco products.
We measured desensitization by applying another 500 ms pulse of ACh (10mM)
3 seconds following the initial stimulus. All HEK-293 cells transfected with α3β2
1/(2^17):1 (n=7) showed very little desensitization when peak2/peak1 was compared
(Mean=0.984 pA ± 0.1857). When the α3 subunit concentration was increased to equal
the concentration of β2 (n=15), little desensitization was observed (Mean=0.9690 pA ±
0.2223) (Figure 13).

Again, a two-tailed T Test confirmed that there was no

significance in desensitization between the two nAChR combinations (Table 5).
Decay Tau
The logarithmic decay (τ) characteristics for both nAChR subunit groups were
very similar and a two-tailed T Test showed no significant differences among them
(Table 6). HEK-293 cells containing α3β2 1/(2^17):1 (n=8) and α3β2 1:1 (n=20) had
mean decay τ values of 1440 ± 605 and 1766 ± 1054, respectively (Figure 14). Again, a
two-tailed T Test confirmed that there was no significance in desensitization between
the two nAChR combinations (Table 5).
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Peak Current
HEK-293 cells expressing α3β2 1/(2^17):1 revealed the largest mean peak value
of 231.7 pA ± 248.9 whereas α3β2 1:1 showed a mean peak value of 70.46 pA ± 45.90
(Figure 15). A two-tailed T Test (P=0.010) together with a Mann- Whitney Test
(P=0.0183) showed significant differences between these two α3β2 nAChR groups
(Table 6).
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Figure 11. 10%-90% Rise times. n=29.
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Unpaired t test
P value
P value summary
Are means signif. different?
(P < 0.05)
One- or two-tailed P value?
t, df
Mann Whitney test
P value
Exact or approximate P
value?
P value summary
Are medians signif. different?
(P < 0.05)
One- or two-tailed P value?
Sum of ranks in column A,B
Mann-Whitney U

0.0006
***
Yes
Two-tailed
t=3.813 df=30
0.0022
Gaussian
Approximation
**
Yes
Two-tailed
75 , 453
30

Table 2. 10%-90% Rise time statistical analysis. A two-tailed T-test (P
value = 0.0006) revealed together with a Mann-Whitney test (P=0.0022)
revealed a significant difference in rise times between these two groups of
α3β2 receptors.
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Figure 12. 90%-10% Decay times for both nAChR groups. n=29.
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Unpaired t test
P value
P value summary
Are means signif. different?
(P < 0.05)
One- or two-tailed P value?
t, df

0.3901
ns
No
Two-tailed
t=0.8721 df=30

Table 3. 90%-10% Decay time statistical analysis. A two-tailed T Test
revealed no significant differences between the two α3β2 groups.
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Figure 13. α3β2 nAChR Desensitization in HEK-293 cells. n=29.
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Unpaired t test
P value
P value summary
Are means signif. different?
(P < 0.05)
One- or two-tailed P value?
t, df

0.8784
ns
No
Two-tailed
t=0.1550 df=20

Table 4. Desensitization statistical analysis.
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Figure 14. Decay tau (τ) for α3β2 in HEK-293 cells. n=29
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Unpaired t test
P value
P value summary
Are means signif. different?
(P < 0.05)
One- or two-tailed P value?
t, df

0.4222
ns
No
Two-tailed
t=0.8156 df=26

Table 5. Decay tau (τ) statistical analysis.
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Figure 15. Peak current for both α3β2 nAChR groups. n=29.
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Unpaired t test
P value
P value summary
Are means signif. different?
(P < 0.05)
One- or two-tailed P value?
t, df
Mann Whitney test
P value
Exact or approximate P
value?
P value summary
Are medians signif. different?
(P < 0.05)
One- or two-tailed P value?
Sum of ranks in column A,B
Mann-Whitney U

0.01
**
Yes
Two-tailed
t=2.781 df=26
0.0183
Gaussian
Approximation
*
Yes
Two-tailed
179 , 227
37

Table 6. Peak current statistical analysis. A two tailed T-test (P value =
0.001) together with a Mann-Whitney Test (P value = 0.0183) revealed
significant differences in peak current amplitude between these two groups of
α3β2 receptors.
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DISCUSSSION
Neuronal nAChR subunits are widely expressed in the hippocampus, and are
thought to participate in a diversity of physiological and pathological processes
associated with cognition and memory (Scoville and Milner 1957; Levin 1992;
Newhouse, Potter et al. 1997; Liu, Kawai et al. 2001). However, the specific cellular
roles of these ion channels in these processes remain largely undetermined (Jones,
Sudweeks et al. 1999). While the major subtype of nAChRs in the hippocampus is
thought to be composed of α7 and α4β2 channels, other subunits (α2−5, α7, and β2−4)
have been shown to be significantly expressed in the CA1 stratum radiatum and
stratum oriens and may be contributing to the formation of functional channels
(McQuiston and Madison 1999; Sudweeks and Yakel 2000). Our single-cell real-time
quantitative RT-PCR data has shown that 8.6% of 93 CA1 hippocampal interneurons
had α3α4α5α7β2 and α3α5β2β3β4, two combinations that were seen in four cells
each.

These two unique combinations were the two most common-single cell

combinations found and α3β2 was a subcomponent among them. α3β2 is the simplest
combination that can make functional nAChR channels from both of these two most
commonly observed expression profiles. Therefore, α3 could be one of the major
components that could contribute to the physiological and pathological processes
occurring in the hippocampus. Our aim is to further understand the selective function
of α3β2 nAChRs in the CA1 region of the hippocampus. The objective in performing
this study was to recreate and characterize functional rat α3β2 neuronal nAChR
channels in HEK-293 cells at expression ratios found with single-cell real-time
quantitative RT-PCR. In addition, as part of my thesis I also looked at the changes in
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α3β2 receptor kinetics when the α3 subunit concentration was altered. To-date, a small
amount of studies have looked at rat α3β2 neuronal nAChRs in HEK-293 cells despite
the number successful studies using Xenopus oocytes (Luetje and Patrick 1991; Elliott,
Ellis et al. 1996; Chavez-Noriega, Crona et al. 1997; Fenster, Rains et al. 1997; Nelson
and Lindstrom 1999; Figl and Cohen 2000). For this reason, our studies are carried out
using HEK-293.
The ion channel properties of recombinant α3-containing neuronal nAChR may
be strongly dependent on the host cell type (Lewis, Harkness et al. 1997). Previous
studies show have shown that α3β2 illustrates a longer decay time and a smaller peak
current when expressed in Xenopus oocytes (Elliott, Ellis et al. 1996). Comparatively,
other studies using HEK-293 cells (Nelson, Wang et al. 2001) reveal that α3β2 did not
produce as long of a decay time which is analogous to our findings. These findings
suggest the possibility of differing α3β2 stoichiometries based on host cell type.
Although α3 and β2 have been shown to express at mRNA ratios (i.e. 1:1) found
within CA1 interneurons, they are capable of functioning at altered ratios in HEK-293
cells. This suggests that there may be a variety of stoichiometries for α3β2 present
within hippocampal interneurons. Other nAChRs such as α4β2 have been proposed to
be expressed within oocytes as (α4)2(β2)3 (Anand, Conroy et al. 1991; Cooper,
Couturier et al. 1991). However, various functional studies have suggested that there is
more than one stoichiometry for the α4β2 nAChR.

subtype (Zwart and Vijverberg

1998). For instance, patch clamp recordings from Xenopus oocytes expressing α4β2
nAChR have demonstrated that single channel conductance depends on the α:β ratio of
mRNA injected into the oocyte (Papke, Boulter et al. 1989). When the relative levels of
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expression of the α4 and β2 were varied by nuclear injection of three α:β ratios into
Xenopus oocytes, different sensitivities to ACh and d-tubucurarine were obtained using
voltage clamp recording (Zwart and Vijverberg 1998).

Recently reported, using

metabolic labeling with [35S]methionine to measure subunit stoichiometry, the majority
of subunit stoichiometry of α4β2 nAChRs expressed in HEK cells was (α4)3(β2)2, yet
long-term (overnight) nicotine exposure increased the proportion of nAChRs with a
(α4)2(β2)3 stoichiometry (Nelson, Kuryatov et al. 2003). The (α4)2(β2)3 stoichiometry
was found to have a higher sensitivity to ACh activation compared to (α4)3(β2)2.
Interestingly, Nelson et al. also demonstrated that transient transfection with additional
β2 subunits increased upregulation of the nAChRs with high sensitivity to activation.
Thus, there is speculation that at least two α4β2 stoichiometries may exist in the
mammalian brain, making low sensitive and high sensitive α4β2 nAChRs (Nelson,
Kuryatov et al. 2003; Moroni, Zwart et al. 2006). The shift in assembly toward the
(α4)2(β2)3 form caused by long-term nicotine exposure could be important in
understanding nicotine addiction.
Other studies have studied the effect of acute and chronic nicotine exposure on
the desensitization and upregulation of different α4β2 subunit ratios [i.e.
1α4:4β2, 2α4:3β2, and 4α4:1β2 (Lopez-Hernandez, Sanchez-Padilla et al. 2004) or
1α4:10β2, 10α4:1β2 (Nelson, Kuryatov et al. 2003; Moroni, Zwart et al. 2006)] expressed
in Xenopus oocytes. Using immunoblotting, Lopez-Hernandez et al. showed that the
presence of the α4 subunit in the oocyte plasmatic membrane increased linearly with
the amount of α4 mRNA injected. Contradictory to our study, the 1α:4β subunit ratio
exhibited the lowest ACh- and nicotine-induced macroscopic current, whereas 4α:1β
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presented the largest currents at all agonist concentrations tested. Lopez-Hernandez et
al. found that chronic nicotine displayed a reduced state of activation in all three α4β2
subunit ratios, and interestingly only the 2α4:3β2 was up-regulated. Both Moroni et al.
and Lopez-Hernandez et al. showed that an increase in α4 to β2 ratio elicits a larger
peak amplitude current, opposite to our findings. Therefore, it is possible that the
subunit type and ratio determines the functional state of activation and up-regulation.
Furthermore, independent structural sites may regulate receptor activation.

This

provides evidence that nAChR subtype kinetics is largely based on subunit composition.
Moreover, it is likely that the relative subunit ratios and the independent structural sites
of α3 and β2 regulate α3β2 kinetics based on different host cell types.
Our knowledge on the pharmacological profile of many two-way combinations
have illustrated differences in nAChR binding and very few pharmacological studies
have been carried out using three-way combinations (Luetje and Patrick 1991; Xiao and
Kellar 2004). In Luetje’s study, an α2β2-expressing oocyte elicited a smaller current
than α3β2-expressing oocytes by an equal concentration of ACh. In sharp contrast, the
current elicited in an α2β2-expressing oocyte by nicotine was much larger current than
an α3β2-expressing oocyte. It’s clear that the α2β3 and α3β2 nAChRs alter their
responses to varying agonists in oocytes.

Few studies have characterized the

pharmacological profile of nAChRs using agonists in HEK293 cells despite successful
studies using oocytes. Xiao et. al. have determined the binding affinities for many
agonists (including ACh and nicotine) at heteromeric nAChRs composed of rat α2−4
subunits in combination with β2 or β4 in HEK-293 cells. α3β2 demonstrated α 4-fold
greater affinity for ACh than α2β2. In addition, α3β2 demonstrated a much higher
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affinity for nicotine compared to α2β2. Accordingly, further studies are needed using
pharmacology on two- and three way nAChR combinations in HEK-293 to further
characterize the pharmacological profile of these channels found in native hippocampal
tissues (Luetje and Patrick 1991; Alkondon and Albuquerque 1993; Chavez-Noriega,
Crona et al. 1997; Xiao and Kellar 2004).
In summary we have demonstrated that rat α3β2 nAChRs are capable of
functional expression in HEK-293 cells at DNA ratios found using single-cell real-time
quantitative RT-PCR. Furthermore, we have demonstrated that α3β2 1/(2^17):1 and
α3β2 1:1 are significantly different in 10%-90% rise time and peak current amplitude.
However, these two groups are not significantly different among the majority of their
functional properties. These findings may help elucidate the functional characteristics
of function nAChRs in native hippocampal CA1 interneurons. This information would
increase our understanding of how nAChRs may be involved in such pathological
conditions of Alzheimer’s disease, schizophrenia, and how nAChRs may be specifically
modulated to treat these conditions with therapeutic drugs. Further studies involving
α2β2, α3β2, and α2α3β2 could further elucidate the properties of nAChRs and the role
they play in synaptic transmission in the hippocampus.
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FUTURE DIRECTIONS
The objective of this work was to heterologously express, in HEK-293 cells, rat
neuronal α3β2 nAChRs to analyze the kinetics of these protein channels. To more
accurately examine the functional properties of this nAChR receptor subtype further
experimentation

including

quantitative

single-cell

RT-PCR,

electrophysiology,

pharmacological, and must be performed.
The techniques currently to identify nAChR receptor subtypes in the
hippocampal interneurons include cellular localization of subunit mRNA (by in situ
hybridization or single-cell real-time quantitative RT-PCR) or proteins (by
immunoprecipitation or immunocytochemistry), and the assessment of subtype
composition

and

immunopurification).

pharmacology

(by

binding

in

tissue

homogenates

or

Many of these techniques could similarly be used to fully

characterize the α3β2 nAChR subtype when transiently expressed in HEK-293 cells.
Single-cell real-time quantitative RT-PCR is highly sensitive and specific and
could be used to determine whether HEK-293 cells are expressing α3β2 at the same
ratios that they were transfected. Interpreting the data obtained using this technique
requires some general caveats: namely, there may not always be a correlation between
mRNA levels and the concentration of surface expressed receptors. The total amount of
subunit proteins must assemble properly to make functional channels.
To further validate the expression α3β2 in HEK-293 cells, surface labeling
using immunohistochemistry along with radioimmuno assays could be employed to
detect and even quantify surface expression of α3β2 nAChRs. However, the use of α3and β2-specific antibodies are not precisely accurate, and evidence exists that they may
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cross-react with other subunits as demonstrated by the similar staining patterns in
tissues obtained from wild-type and subunit knockout mice (Jones and Wonnacott
2005). Also, not all nAChR subunits have antibodies that are accessible for use yet.
Pharmacological studies include a pharmacological comparison using alternative
nicotinic agonists (i.e. nicotine, cytisine, choline, epibatidine, and 1, 1-dimethyl-4phenylpiperazinium) will provide an agonist profile for α3β2. Rapid application of
different nicotinic agonists at varying concentrations will make available a
concentration/response family of currents.

The dose concentration/response

relationships for each nicotinic agonist could therefore be plotted and the EC50 values
for each agonist could then be determined. In addition, the maximum responses as well
as the efficacy of each nicotinic agonist could be compared to the efficacy of ACh.
The recent discovery of Conus peptides in the venom of cone snails has made it
possible to discriminate subtypes in both binding and functional tests. One typical
example is αConotoxin MII (αCntxMII), which can block the response of ACh to
heterologously expressed α6β2 and α3β2 subtypes. The specificity of αCntxMII for
native subtypes has been demonstrated in previous binding studies and it’s use has
helped to define different interfaces in the same receptor in vivo (McIntosh, Azam et al.
2004; Gotti, Zoli et al. 2006). The block of α3β2 in HEK-293 cells with αCntxMII in
the presence of ACh would further confirm the capability of α3β2 expression in HEK293 cells.
These and other similar studies would help to further elucidate the role of
various neuronal nAChR subtypes and help explain why there is so much functional
diversity in this neurotransmitter system.
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